Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-02-21
Original SEC Filing: Click here

---

Webplus: SVA/20200221/6-K/2_EX-4.1/000.htm SEC Original: tm209518d1_ex4-1.htm
SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT Effective as of February 19, 2020 Amendment Amended and Restated Rights Agreement Company Rights Agent This Amendment (this “ WHEREAS, the Company and the Rights Agent have heretofore executed and entered into the Amended and Restated Rights Agreement; WHEREAS, the Amended and

---

---

Webplus: SVA/20200221/6-K/3_EX-99.1/000.htm SEC Original: tm209518d1_ex99-1.htm
Sinovac Amends Shareholder Rights Plan About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac’s product portfolio includes vaccines against enterovirus71 (EV71), hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), varicella vaccine and mumps. Healive,

---

---

Webplus: SVA/20200221/6-K/1/000.htm SEC Original: tm209518d1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-02-21CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200